Tumour characteristics | Number of patients | Proportion of patients according to diagnosis time (percent) | P value | |||
---|---|---|---|---|---|---|
<3 months | 3-6 months | >6 months | ||||
Clinical stage | Stage 1 | 18 | 94.4 | 5.6 | 0.0 | <0.0001 |
Stage 2 | 51 | 74.5 | 23.5 | 2.0 | ||
Stage 3 | 108 | 2.8 | 10.2 | 87.0 | ||
Stage 4 | 23 | 0.0 | 0.0 | 100.0 | ||
Clinical stage | Early stages | 69 | 79.7 | 18.8 | 1.4 | <0.0001 |
Late stages | 131 | 2.3 | 8.4 | 89.3 | ||
T | T 1 | 25 | 96.0 | 4.0 | 0.0 | <0.0001 |
T 2 | 54 | 60.8 | 33.3 | 5.9 | ||
T 3 | 78 | 4.3 | 25.7 | 70.0 | ||
T 4 | 43 | 0.0 | 4.8 | 95.2 | ||
N | N 0 | 50 | 80.0 | 18.0 | 2.0 | <0.0001 |
N 1 | 76 | 22.4 | 31.6 | 46.1 | ||
N 2 | 58 | 1.7 | 12.1 | 86.2 | ||
N 3 | 16 | 0.0 | 0.0 | 100.0 | ||
M | M 0 | 177 | 32.8 | 21.5 | 45.8 | <0.0001 |
M 1 | 23 | 0.0 | 8.7 | 91.3 |